May 7, 2019
(The Scientist) – In a first-of-its-kind clinical trial, a natural killer cell immunotherapy derived from induced pluripotent stem cells is being tested for safety in 64 patients with a variety of solid tumors. The first patients received the cells in … Read More
April 30, 2019
(The Scientist) – The results of the first clinical trial using induced pluripotent stem cells from donors point to signs of efficacy for treating the progressive form of blindness known as age-related macular degeneration. Last week, the Japanese team of … Read More
April 25, 2019
(The New Atlantis) – In the past, embryonic stem cells were used for these experiments. But researchers have begun to favor a relatively recent innovation: induced pluripotent stem cells, which have essentially the same properties as embryonic stem cells but … Read More
March 22, 2019
(New Atlas) – Thirteen years on, Yamanaka has earned a Nobel Prize in Physiology or Medicine for his discovery (jointly award to him and Sir John B. Gurdon in 2012), and scientists have built on his work and tweaked his … Read More
February 18, 2019
(Reuters) – Japanese scientists will test the use of human-induced pluripotent stem cells (iPS) to treat spinal cord injuries, a health ministry panel that approved the research project said on Monday. The research team from Tokyo’s Keio University planned to … Read More